Skip to content
Buy This GLP
← Research
Evidence

Semaglutide and Blood Eosinophils: A 371-Patient Before-and-After Study

Median eosinophil counts fell from 160 to 110 per microliter after people started semaglutide. The single-center study had no control group and measured no asthma outcome.

Editorial profile: Neil SandersBuy This GLP Editorial Team6 min read
Median blood eosinophil count, per µL160110beforeafterbelow 150/µL:44.2%rose to65.8%371 patients, one clinic, no control group, no asthma outcome.

Research on GLP-1 drugs and asthma attacks looks at whether patients have fewer exacerbations. This study asked a different question. A Shanghai clinic tracked eosinophil counts in people prescribed semaglutide [1]. Clinicians use these white blood cells to help identify types of asthma and assess who may respond to certain biologic drugs.

Counts fell. The median went from 160 to 110 per microliter, the eosinophil percentage from 2.20% to 1.60%, and the proportion of people sitting below the commonly used 150 threshold rose from 44.20% to 65.79%. Reductions appeared in people who started above the threshold and in those who started below it.

The median percentage decline was 31.58% in the group with a BMI below 28 and 21.04% in the group at or above 28 (P = 0.037) [1]. In the adjusted analysis, the starting eosinophil count was the only independent predictor of the decline. The study design leaves open how much of the change came from semaglutide, weight change or other factors.

Frequently asked

Does semaglutide help asthma?
This study cannot say. It measured blood eosinophil counts and reported no symptoms, exacerbations, inhaler use or lung function, and had no control group.
Why would the eosinophil count matter?
It is used to phenotype asthma and to decide who is likely to respond to certain biologic treatments, so a drug that moves the count could affect how a specialist reads it.
Was the fall just from weight loss?
The study could not isolate the role of weight change. People in the lower-BMI group had a larger percentage decline, and the starting eosinophil count was the only independent predictor in the adjusted analysis.

Sources

  1. [1] Wu Y, Lin Y, Wu J, Zhao L, Lin Y, Chen W, Zhu Y, Wang Y, Zhang M, Bao W (2026). Effect of GLP-1RA on blood eosinophil levels in adults: a real-world study BMC Pulmonary Medicine. PMID 42401898

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence